Andrew W. Craig

5.2k total citations
135 papers, 4.1k citations indexed

About

Andrew W. Craig is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Andrew W. Craig has authored 135 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 30 papers in Immunology and 23 papers in Oncology. Recurrent topics in Andrew W. Craig's work include Mast cells and histamine (15 papers), Cell Adhesion Molecules Research (15 papers) and Carcinogens and Genotoxicity Assessment (11 papers). Andrew W. Craig is often cited by papers focused on Mast cells and histamine (15 papers), Cell Adhesion Molecules Research (15 papers) and Carcinogens and Genotoxicity Assessment (11 papers). Andrew W. Craig collaborates with scholars based in Canada, United States and United Kingdom. Andrew W. Craig's co-authors include Nahum Sonenberg, Peter A. Greer, H. Jackson, B.W. Fox, Peter Truesdell, Ashkan Haghighat, John S. Bertram, Peter O’Connor, Neal K. Clapp and Yuri V. Svitkin and has published in prestigious journals such as Nature, Science and Journal of the American Chemical Society.

In The Last Decade

Andrew W. Craig

132 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew W. Craig Canada 37 2.1k 732 728 545 471 135 4.1k
Honami Naora United States 30 2.2k 1.1× 848 1.2× 864 1.2× 693 1.3× 265 0.6× 90 3.7k
Bernard Haendler Germany 40 3.6k 1.7× 681 0.9× 926 1.3× 529 1.0× 356 0.8× 110 5.4k
Werner Machleidt Germany 40 2.6k 1.2× 400 0.5× 604 0.8× 882 1.6× 675 1.4× 107 4.7k
Bert Schutte Netherlands 22 2.2k 1.0× 776 1.1× 925 1.3× 453 0.8× 456 1.0× 43 4.4k
Nils R. Ringertz Sweden 42 2.7k 1.3× 402 0.5× 577 0.8× 245 0.4× 423 0.9× 152 4.8k
Åke Lundwall Sweden 39 1.5k 0.7× 813 1.1× 381 0.5× 535 1.0× 171 0.4× 100 5.0k
Steven W. Sherwood United States 30 2.4k 1.1× 568 0.8× 649 0.9× 323 0.6× 566 1.2× 42 3.7k
P. Galand Belgium 29 1.2k 0.6× 716 1.0× 652 0.9× 326 0.6× 240 0.5× 140 3.3k
Daniel J. Donoghue United States 44 4.2k 2.0× 384 0.5× 1.1k 1.6× 391 0.7× 1.1k 2.3× 127 5.6k
El–Nasir Lalani United Kingdom 38 2.7k 1.3× 1.1k 1.5× 1.1k 1.5× 626 1.1× 345 0.7× 119 5.1k

Countries citing papers authored by Andrew W. Craig

Since Specialization
Citations

This map shows the geographic impact of Andrew W. Craig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew W. Craig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew W. Craig more than expected).

Fields of papers citing papers by Andrew W. Craig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew W. Craig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew W. Craig. The network helps show where Andrew W. Craig may publish in the future.

Co-authorship network of co-authors of Andrew W. Craig

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew W. Craig. A scholar is included among the top collaborators of Andrew W. Craig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew W. Craig. Andrew W. Craig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Truesdell, Peter, Jessica Chang, Meiou Dai, et al.. (2024). Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes. npj Precision Oncology. 8(1). 186–186. 2 indexed citations
2.
Jiang, Yun, Rebecca L. Grange, Murugan Subaramanian, et al.. (2024). Toward a Template for Synthetic Actin-Targeting Macrolide Analogues That Inhibit Cancer Cell Invasiveness. Journal of Medicinal Chemistry. 67(7). 5315–5332.
3.
Purkis, Sam J., Peter K. Swart, Arash Sharifi, et al.. (2022). Discovery of the deep-sea NEOM Brine Pools in the Gulf of Aqaba, Red Sea. Communications Earth & Environment. 3(1). 13 indexed citations
4.
Young, Stephanie, Jae Hoon Lee, Violeta Chiţu, et al.. (2019). Mast cells enhance sterile inflammation in chronic nonbacterial osteomyelitis. Disease Models & Mechanisms. 12(8). 12 indexed citations
5.
Newsted, Daniel, Kathleen Watt, Sarah Nersesian, et al.. (2018). Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models. OncoImmunology. 8(2). e1539613–e1539613. 36 indexed citations
6.
Truesdell, Peter, et al.. (2017). Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers. Breast Cancer Research. 19(1). 110–110. 47 indexed citations
7.
Watt, Kathleen, Peter Truesdell, Jalna Meens, et al.. (2015). Endophilin A2 Promotes TNBC Cell Invasion and Tumor Metastasis. Molecular Cancer Research. 13(6). 1044–1055. 19 indexed citations
8.
Ahn, Joseph, Peter Truesdell, Jalna Meens, et al.. (2013). Fer Protein-Tyrosine Kinase Promotes Lung Adenocarcinoma Cell Invasion and Tumor Metastasis. Molecular Cancer Research. 11(8). 952–963. 44 indexed citations
9.
Everingham, Stephanie, et al.. (2012). FES Kinase Promotes Mast Cell Recruitment to Mammary Tumors via the Stem Cell Factor/KIT Receptor Signaling Axis. Molecular Cancer Research. 10(7). 881–891. 12 indexed citations
10.
Hu, Jinghui, Peter Truesdell, Harish Chander, et al.. (2011). Cdc42-interacting protein 4 is a Src substrate that regulates invadopodia and invasiveness of breast tumors by promoting MT1-MMP endocytosis. Journal of Cell Science. 124(10). 1739–1751. 43 indexed citations
11.
McPherson, Victor, Stephanie Everingham, Julie A. Smith, et al.. (2009). SH2 Domain-Containing Phosphatase-2 Protein-Tyrosine Phosphatase Promotes FcεRI-Induced Activation of Fyn and Erk Pathways Leading to TNFα Release from Bone Marrow-Derived Mast Cells. The Journal of Immunology. 183(8). 4940–4947. 23 indexed citations
12.
Vultur, Adina, Jun Cao, Rozanne Arulanandam, et al.. (2004). Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells. Oncogene. 23(15). 2600–2616. 89 indexed citations
13.
Senis, Yotis A., Andrew W. Craig, & Peter A. Greer. (2003). Fps/Fes and Fer protein-tyrosinekinases play redundant roles in regulating hematopoiesis. Experimental Hematology. 31(8). 673–681. 25 indexed citations
14.
McCafferty, Donna‐Marie, Andrew W. Craig, Yotis A. Senis, & Peter A. Greer. (2002). Absence of Fer Protein-Tyrosine Kinase Exacerbates Leukocyte Recruitment in Response to Endotoxin. The Journal of Immunology. 168(10). 4930–4935. 38 indexed citations
15.
16.
Jackson, Scott M., et al.. (1970). Lymphocyte transformation changes during the clinical course of Hodgkin's disease. Cancer. 25(4). 843–850. 51 indexed citations
17.
Fox, B.W., H. Jackson, Andrew W. Craig, & T. D. Glover. (1963). EFFECTS OF ALKYLATING AGENTS ON SPERMATOGENESIS IN THE RABBIT. Reproduction. 5(1). 13–NP. 25 indexed citations
18.
Jackson, H., B.W. Fox, & Andrew W. Craig. (1961). ANTIFERTILITY SUBSTANCES AND THEIR ASSESSMENT IN THE MALE RODENT. Reproduction. 2(4). 447–465. 107 indexed citations
19.
Craig, Andrew W., B.W. Fox, & Helen C. Jackson. (1961). EFFECT OF RADIATION ON MALE MOUSE AND RAT FERTILITY. Reproduction. 2(4). 466–472. 15 indexed citations
20.
Craig, Andrew W., et al.. (1953). Some annelid and sipunculid worms of the Bimini region. Biodiversity Heritage Library (Smithsonian Institution). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Honami Naora Breakdown of academic impact, for papers by Bernard Haendler Breakdown of academic impact, for papers by Werner Machleidt Breakdown of academic impact, for papers by Bert Schutte Breakdown of academic impact, for papers by Nils R. Ringertz Breakdown of academic impact, for papers by Åke Lundwall Breakdown of academic impact, for papers by Steven W. Sherwood Breakdown of academic impact, for papers by P. Galand Breakdown of academic impact, for papers by Daniel J. Donoghue Breakdown of academic impact, for papers by El–Nasir Lalani
Rankless by CCL
2026